author-photo

Joanna Jasinska

Medical University of Vienna

22

Papers

322

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults

2021
Show All
- Source
- Cite
- Save
Citations (3)
Absent Antibody Production Following COVID19 Vaccination with mRNA in Patients Under Immunosuppressive Treatments

2021 Vaccine
Show All
- Source
- Cite
- Save
Citations (0)
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (4)
1840PReduced antibody levels and high seronegativity rates against vaccine preventable diseases pose a risk factor for infections in patients with solid and hematologic cancers

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program

2019 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (19)
Prevention of Birch Pollen-Related Food Allergy by Mucosal Treatment with Multi-Allergen-Chimers in Mice

2012 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (10)
Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.

2011 Vaccine
Show All
- Source
- Cite
- Save
Citations (13)
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

2010 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (67)
Abstract #722: A HER2 multi-peptide virosome vaccine induced HER-2 specific antibodies in patients with metastatic breast cancer: final results of a phase I study to evaluate safety and immunogenicity

2009 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A phase I study to evaluate safety, immunogenicity and antitumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)